当前位置:首页 - 行情中心 - 绿康生化(002868) - 财务分析 - 利润表

绿康生化

(002868)

  

流通市值:22.75亿  总市值:23.14亿
流通股本:1.53亿   总股本:1.55亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入397,672,979.94230,041,548.11100,190,694.85329,850,238.49
营业收入397,672,979.94230,041,548.11100,190,694.85329,850,238.49
二、营业总成本471,642,652.69253,533,136.32111,167,600.07417,116,656.05
营业成本399,085,291.27206,797,161.0187,421,034.65339,103,843.72
税金及附加2,999,552.681,964,354.62982,738.083,843,239.91
销售费用10,859,795.616,929,683.053,398,682.8510,815,073.46
管理费用18,849,901.3112,005,931.537,027,014.8227,343,876.16
研发费用19,620,456.1513,128,428.735,610,427.6221,824,916.67
财务费用20,227,655.6712,707,577.386,727,702.0514,185,706.13
其中:利息费用14,401,488.7111,559,529.033,610,874.5816,220,887.39
其中:利息收入228,148.76181,714.9114,482.87177,536.38
加:投资收益21,613,875.3524,020,254.7320,610,351.67-10,119,801.77
资产处置收益-36,213.4336,213.43--
资产减值损失(新)-32,405,786.76-45,981,005.81-23,926,073.25-48,074,098.78
信用减值损失(新)-1,226,547.98-823,234.97-466,892.34-1,431,822.96
其他收益2,152,302.451,477,225.564,189,281.4513,132,407.57
营业利润平衡项目0000
四、营业利润-83,872,043.12-44,762,135.27-10,570,237.69-133,759,733.5
加:营业外收入109,509.1659,929.1670,998.76240,024.76
减:营业外支出4,279,785.454,174,484.9310,441590,612.56
利润总额平衡项目0000
五、利润总额-88,042,319.41-48,876,691.04-10,509,679.93-134,110,321.3
减:所得税费用-1,417,354.75-2,009,142.6-92,815.96-11,388,771.43
六、净利润-86,624,964.66-46,867,548.44-10,416,863.97-122,721,549.87
持续经营净利润-86,624,964.66-46,867,548.44-10,416,863.97-122,721,549.87
归属于母公司股东的净利润-86,079,986.84-46,665,167.62-10,145,375.67-121,938,109.79
少数股东损益-544,977.82-202,380.82-271,488.3-783,440.08
(一)基本每股收益-0.56-0.3-0.07-0.79
(二)稀释每股收益-0.56-0.3-0.07-0.79
九、综合收益总额-86,624,964.66-46,867,548.44-10,416,863.97-122,721,549.87
归属于母公司股东的综合收益总额-86,079,986.84-46,665,167.62-10,145,375.67-121,938,109.79
归属于少数股东的综合收益总额-544,977.82-202,380.82-271,488.3-783,440.08
公告日期2023-10-302023-08-312023-04-292023-04-15
审计意见(境内)标准无保留意见
TOP↑